查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493251

肺癌液態切片市場規模、佔有率、趨勢分析報告：按樣本類型、按生物標記、按技術、按最終用途、按臨床應用、按產品、按地區、細分市場預測，2024-2030年

Lung Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Sample Type, By Biomarker, By Technology, By End-use, By Clinical Application, By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

肺癌液態切片市場的成長和趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球肺癌液態切片市場規模將達23.5億美元，2024年至2030年複合年成長率為13.3%。

液態切片提供了傳統組織切片檢查的非侵入性替代方案，可以早期發現肺癌。診斷產業正向精準醫療邁進，這需要準確、全面的診斷工具。液態切片是一種很有前景的解決方案，可為個人化治療計劃提供資訊。

由於發現晚期和死亡率高等因素，整體存活率較低。吸菸和接觸菸草等生活方式習慣是一些重要的危險因素，約佔全球肺癌病例的 80%。根據世界衛生組織（WHO）統計，2020年全球有22.3%的人口消費菸草，其中男性為36.7%，女性為7.8%。菸草每年還造成超過 800 萬人死亡，其中估計有 130 萬名二手菸者。

公司正在推出新技術和產品來篩檢肺癌。例如，德爾福診斷公司於 2023 年 10 月推出了一項血液檢查來篩檢肺癌。預計新產品的推出量增加將推動市場發展。

肺癌液態切片市場報告亮點

  • 根據樣本類型，基於血液樣本的細分市場在 2023 年佔據主導地位。這是由於這種樣本類型的非侵入性、可重複性、即時監測能力、早期檢測和成本效益。
  • 根據生物標記，循環核酸片段將在 2023 年引領市場，因為即使癌症處於早期階段，也可以在血液樣本中以非常低的濃度檢測到它們。
  • 從技術來看，多基因平行分析（NGS）領域將在 2023 年佔據市場主導地位。
  • 由於肺癌盛行率增加、生活方式改變、醫療保健進步和報銷政策的可用性等因素，北美在 2023 年將主導肺癌液態切片市場。
  • 例如，根據美國癌症協會期刊報道，2022 年美國將新增約 1,918,030 例癌症病例，其中每天約有 350 例死於肺癌，這是癌症死亡的主要原因。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章肺癌液態切片市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 肺癌液態切片市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章肺癌液態切片市場：樣本類型估計和趨勢分析

  • 樣本類型市場佔有率，2023 年和 2030 年
  • 細分儀表板
  • 按樣本類型分類的肺癌液態切片市場展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 基於血液樣本
  • 其他

第5章肺癌液態切片市場：生物標記估計和趨勢分析

  • 2023年及2030年生物標記物市場佔有率
  • 細分儀表板
  • 基於生物標記的肺癌液態切片市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 循環核酸
  • CTC
  • 胞外體/微泡
  • 循環蛋白

第6章肺癌液態切片市場：技術評估與趨勢分析

  • 2023年及2030年技術市場佔有率
  • 細分儀表板
  • 按技術前景分類的肺癌液態切片市場
  • 2018-2030年市場規模、預測及趨勢分析
  • 多基因並行分析（NGS）
  • 單基因分析（PCR 微陣列）

第7章肺癌液態切片市場：最終用途估計和趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 肺癌液態切片市場：最終用途展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院/實驗室
  • 專科診所
  • 學術/研究中心
  • 其他

第8章肺癌液態切片市場：臨床應用預估及趨勢分析

  • 2023 年和 2030 年臨床應用市場佔有率
  • 細分儀表板
  • 肺癌液態切片市場臨床應用前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院/實驗室
  • 專科診所
  • 學術/研究中心
  • 其他

第9章肺癌液態切片市場：產品評估和趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 肺癌液態切片市場：按產品分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 裝置
  • 消費性套件/試劑
  • 軟體服務

第10章肺癌液態切片市場：區域估計與趨勢分析

  • 2023 年和 2030 年按地區分類的市場佔有率佔有率
  • 肺癌液態切片市場的區域展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第11章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • CARDIFF ONCOLOGY, INC.
    • CareDx
    • Eurofins Scientific
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd
    • Guardant Health
    • Illumina, Inc.
    • LungLife AI, Inc.
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • QIAGEN
    • Thermo Fisher Scientific Inc.
Product Code: GVR-4-68040-267-0

Lung Cancer Liquid Biopsy Market Growth & Trends:

The global lung cancer liquid biopsy market size is anticipated to reach USD 2.35 billion by 2030, growing at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, enabling earlier detection of lung cancer. The diagnostics industry is moving towards precision medicine, which requires accurate and comprehensive diagnostic tools. Liquid biopsies offer a promising solution for providing information for personalized treatment plans.

Factors such as late detection and high mortality rates result in a decline in the overall survival rate. Lifestyle habits such as cigarette smoking and tobacco exposure are some of the significant risk factors, contributing to approximately 80% of the total lung cancer cases worldwide. According to the World Health Organization (WHO), in 2020, 22.3% of the world's population consumed tobacco, which constitutes 36.7% of men and 7.8% of the total women. It also states that tobacco causes the deaths of more than 8 million people each year, including an estimated 1.3 million passive smokers.

Companies are launching newer technologies and products to screen lung cancers. For instance, Delfi Diagnostics launched its blood test to screen for lung cancer in October 2023. This increasing number of launches involving newer launches is anticipated to propel the market.

Lung Cancer Liquid Biopsy Market Report Highlights:

  • Based on sample type, the blood sample-based segment dominated the market in 2023. This can be attributed to the non-invasive nature, repeatability, real-time monitoring capabilities, early detection, and cost-effectiveness of this sample type.
  • Based on biomarker, the circulating nucleic acids segment led the market in 2023 as it can be detected at very low concentrations in blood samples, even when cancer is at an early stage.
  • Based on technology, the multi-gene-parallel analysis (NGS) segment dominated the market in 2023.
  • North America dominated the market for lung cancer liquid biopsy in 2023, owing to factors such as the increasing prevalence of lung cancer, changes in lifestyles, advancements in healthcare, and availability of reimbursement policies.
  • For instance, according to the American Cancer Society Journals, in 2022, approximately 1,918,030 new cancer cases were observed in the U.S., which included approximately 350 deaths each day from lung cancer, the leading cause of cancer death.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Sample Type
    • 1.2.2. Biomarker
    • 1.2.3. Technology
    • 1.2.4. End-use
    • 1.2.5. Clinical Application
    • 1.2.6. Product
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Sample Type Outlook
    • 2.2.2. Biomarker Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End-use Outlook
    • 2.2.5. Clinical Application Outlook
    • 2.2.6. Product Outlook
  • 2.3. Competitive Insights

Chapter 3. Lung Cancer Liquid Biopsy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Lung Cancer Liquid Biopsy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Lung Cancer Liquid Biopsy Market: Sample Type Estimates & Trend Analysis

  • 4.1. Sample Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Lung Cancer Liquid Biopsy Market by Sample Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Blood Sample Based
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Others
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Lung Cancer Liquid Biopsy Market: Biomarker Estimates & Trend Analysis

  • 5.1. Biomarker Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Lung Cancer Liquid Biopsy Market by Biomarker Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Circulating Nucleic Acids
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. CTC
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Exosomes/Microvesicles
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Circulating Proteins
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Lung Cancer Liquid Biopsy Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Lung Cancer Liquid Biopsy Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Multi-gene-parallel Analysis (NGS)
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Single Gene Analysis (PCR Microarrays)
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Lung Cancer Liquid Biopsy Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Lung Cancer Liquid Biopsy Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Hospitals and Laboratories
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Specialty Clinics
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Academic and Research Centers
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Lung Cancer Liquid Biopsy Market: Clinical Application Estimates & Trend Analysis

  • 8.1. Clinical Application Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Lung Cancer Liquid Biopsy Market by Clinical Application Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Therapy Selection
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Treatment Monitoring
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Early Cancer Screening
      • 8.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Recurrence Monitoring
      • 8.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Others
      • 8.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Lung Cancer Liquid Biopsy Market: Product Estimates & Trend Analysis

  • 9.1. Product Market Share, 2023 & 2030
  • 9.2. Segment Dashboard
  • 9.3. Lung Cancer Liquid Biopsy Market by Product Outlook
  • 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 9.4.1. Instruments
      • 9.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Consumables Kits and Reagents
      • 9.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Software and Services
      • 9.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Lung Cancer Liquid Biopsy Market: Region Estimates & Trend Analysis

  • 10.1. Regional Market Share, 2023 & 2030
  • 10.2. Lung Cancer Liquid Biopsy Market by Region Outlook
  • 10.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 10.3.1. North America
      • 10.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.1.2. U.S.
      • 10.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.1.3. Canada
      • 10.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.2. Europe
      • 10.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.2. UK
      • 10.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.3. Germany
      • 10.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.4. France
      • 10.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.5. Italy
      • 10.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.6. Spain
      • 10.3.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.7. Denmark
      • 10.3.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.8. Sweden
      • 10.3.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.9. Norway
      • 10.3.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.3. Asia Pacific
      • 10.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.2. Japan
      • 10.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.3. China
      • 10.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.4. India
      • 10.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.5. Thailand
      • 10.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.6. South Korea
      • 10.3.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.7. Australia
      • 10.3.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.4. Latin America
      • 10.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.2. Brazil
      • 10.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.3. Mexico
      • 10.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.4. Argentina
      • 10.3.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.5. Middle East and Africa
      • 10.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.2. South Africa
      • 10.3.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.3. Saudi Arabia
      • 10.3.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.4. UAE
      • 10.3.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.5. Kuwait
      • 10.3.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 11.2. Company/Competition Categorization
  • 11.3. Vendor Landscape
    • 11.3.1. List of key distributors and channel partners
    • 11.3.2. Key customers
    • 11.3.3. Key company heat map analysis, 2023
  • 11.4. Company Profiles
    • 11.4.1. Agilent Technologies Inc.
      • 11.4.1.1. Company overview
      • 11.4.1.2. Financial performance
      • 11.4.1.3. Product benchmarking
      • 11.4.1.4. Strategic initiatives
    • 11.4.2. Bio-Rad Laboratories, Inc.
      • 11.4.2.1. Company overview
      • 11.4.2.2. Financial performance
      • 11.4.2.3. Product benchmarking
      • 11.4.2.4. Strategic initiatives
    • 11.4.3. CARDIFF ONCOLOGY, INC.
      • 11.4.3.1. Company overview
      • 11.4.3.2. Financial performance
      • 11.4.3.3. Product benchmarking
      • 11.4.3.4. Strategic initiatives
    • 11.4.4. CareDx
      • 11.4.4.1. Company overview
      • 11.4.4.2. Financial performance
      • 11.4.4.3. Product benchmarking
      • 11.4.4.4. Strategic initiatives
    • 11.4.5. Eurofins Scientific
      • 11.4.5.1. Company overview
      • 11.4.5.2. Financial performance
      • 11.4.5.3. Product benchmarking
      • 11.4.5.4. Strategic initiatives
    • 11.4.6. Exact Sciences Corporation
      • 11.4.6.1. Company overview
      • 11.4.6.2. Financial performance
      • 11.4.6.3. Product benchmarking
      • 11.4.6.4. Strategic initiatives
    • 11.4.7. F. Hoffmann-La Roche Ltd
      • 11.4.7.1. Company overview
      • 11.4.7.2. Financial performance
      • 11.4.7.3. Product benchmarking
      • 11.4.7.4. Strategic initiatives
    • 11.4.8. Guardant Health
      • 11.4.8.1. Company overview
      • 11.4.8.2. Financial performance
      • 11.4.8.3. Product benchmarking
      • 11.4.8.4. Strategic initiatives
    • 11.4.9. Illumina, Inc.
      • 11.4.9.1. Company overview
      • 11.4.9.2. Financial performance
      • 11.4.9.3. Product benchmarking
      • 11.4.9.4. Strategic initiatives
    • 11.4.10. LungLife AI, Inc.
      • 11.4.10.1. Company overview
      • 11.4.10.2. Financial performance
      • 11.4.10.3. Product benchmarking
      • 11.4.10.4. Strategic initiatives
    • 11.4.11. Myriad Genetics, Inc.
      • 11.4.11.1. Company overview
      • 11.4.11.2. Financial performance
      • 11.4.11.3. Product benchmarking
      • 11.4.11.4. Strategic initiatives
    • 11.4.12. Natera, Inc.
      • 11.4.12.1. Company overview
      • 11.4.12.2. Financial performance
      • 11.4.12.3. Product benchmarking
      • 11.4.12.4. Strategic initiatives
    • 11.4.13. QIAGEN
      • 11.4.13.1. Company overview
      • 11.4.13.2. Financial performance
      • 11.4.13.3. Product benchmarking
      • 11.4.13.4. Strategic initiatives
    • 11.4.14. Thermo Fisher Scientific Inc.
      • 11.4.14.1. Company overview
      • 11.4.14.2. Financial performance
      • 11.4.14.3. Product benchmarking
      • 11.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 5 North America lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 6 North America lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 7 North America lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 9 North America lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 11 U.S. lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 12 U.S. lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 15 U.S. lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 17 Canada lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 18 Canada lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Canada lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Canada lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 21 Canada lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 24 Europe lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 25 Europe lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Europe lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Europe lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 28 Europe lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 29 UK lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 30 UK lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 31 UK lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 32 UK lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 UK lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 34 UK lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 36 Germany lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 37 Germany lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Germany lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Germany lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 40 Germany lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 41 France lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 42 France lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 43 France lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 44 France lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 46 France lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Italy lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 48 Italy lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 49 Italy lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Italy lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Italy lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 52 Italy lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Spain lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 54 Spain lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 55 Spain lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Spain lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Spain lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 58 Spain lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 59 Denmark lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 60 Denmark lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 61 Denmark lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Denmark lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 64 Denmark lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 65 Sweden lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 66 Sweden lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 67 Sweden lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Sweden lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 70 Sweden lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 72 Norway lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 73 Norway lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Norway lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Norway lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 76 Norway lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 84 Japan lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 85 Japan lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 86 Japan lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Japan lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Japan lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 89 Japan lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 90 China lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 91 China lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 92 China lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 93 China lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 China lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 95 China lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 96 India lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 97 India lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 98 India lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 99 India lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 India lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 101 India lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 102 Thailand lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 103 Thailand lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 104 Thailand lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 105 Thailand lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 107 Thailand lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 108 South Korea lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 109 South Korea lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 110 South Korea lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 111 South Korea lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 South Korea lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 113 South Korea lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 114 Australia lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 115 Australia lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 116 Australia lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Australia lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Australia lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 119 Australia lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 120 Latin America lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 121 Latin America lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 122 Latin America lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 123 Latin America lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Latin America lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Latin America lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 126 Latin America lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 127 Brazil lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 128 Brazil lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 129 Brazil lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Brazil lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 131 Brazil lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 132 Brazil lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 133 Mexico lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 134 Mexico lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 135 Mexico lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 136 Mexico lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 Mexico lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 138 Mexico lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 139 Argentina lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 140 Argentina lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 141 Argentina lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 142 Argentina lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 Argentina lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 144 Argentina lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 145 MEA lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 146 MEA lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 147 MEA lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 148 MEA lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 149 MEA lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 150 MEA lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 151 MEA lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 152 South Africa lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 153 South Africa lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 154 South Africa lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 155 South Africa lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 156 South Africa lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 157 South Africa lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 158 Saudi Arabia lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 159 Saudi Arabia lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 160 Saudi Arabia lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 161 Saudi Arabia lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 162 Saudi Arabia lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 163 Saudi Arabia lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 164 UAE lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 165 UAE lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 166 UAE lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 167 UAE lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 168 UAE lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 169 UAE lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 170 Kuwait lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 171 Kuwait lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 172 Kuwait lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 173 Kuwait lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 174 Kuwait lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 175 Kuwait lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Lung cancer liquid biopsy market: market outlook
  • Fig. 9 Lung cancer liquid Biopsy Market Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Lung cancer liquid biopsy market driver impact
  • Fig. 14 Lung cancer liquid biopsy market restraint impact
  • Fig. 15 Lung cancer liquid biopsy market: Sample type movement analysis
  • Fig. 16 Lung cancer liquid biopsy market: Sample type outlook and key takeaways
  • Fig. 17 Blood sample-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Lung cancer liquid biopsy market: Biomarker movement analysis
  • Fig. 20 Lung cancer liquid biopsy market: Biomarker outlook and key takeaways
  • Fig. 21 Circulating nucleic acids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 CTC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Exosomes/microvesicles market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Circulating proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Lung cancer liquid biopsy market: Technology movement analysis
  • Fig. 26 Lung cancer liquid biopsy market: Technology outlook and key takeaways
  • Fig. 27 Multi-gene-parallel analysis (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Single gene analysis (PCR Microarrays) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Lung cancer liquid biopsy market: End-use movement analysis
  • Fig. 30 Lung cancer liquid biopsy market: End-use outlook and key takeaways
  • Fig. 31 Hospitals and laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Specialty clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Academic and research centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Lung cancer liquid biopsy market: Clinical application movement analysis
  • Fig. 36 Lung cancer liquid biopsy market: Clinical application outlook and key takeaways
  • Fig. 37 Therapy selection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Treatment monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Early cancer screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Recurrence monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Lung cancer liquid biopsy market: Product movement analysis
  • Fig. 43 Lung cancer liquid biopsy market: Product outlook and key takeaways
  • Fig. 44 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Consumables kits and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)